-- 根據澳洲證券交易所週二提交的文件顯示，澳洲臨床實驗室（ASX：ACL）否認了米歇爾·拉布-伊万諾夫（Michelle Raab-Ivanov）在維多利亞州最高法院提起的代表訴訟中的指控，併計劃「全力」應訴。 文件稱，訴訟代表的是2022年7月15日之前曾是該公司和/或其子公司Medlab Pathology的客戶，且其個人資訊在2022年2月Medlab Pathology遭受網路攻擊後受到影響的個人。 根據文件，該訴訟旨在根據涉嫌違反澳洲消費者法的行為，為受影響的個人尋求損害賠償。
Related Articles
Asia
Origin Energy Reports Lower March Quarter Production
Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.The company reported commodity revenue of AU$1.86 billion for the quarter, down from AU$ 2.31 billion a year ago, per the filing.Origin Energy also said its electricity sales volume increased 4% from a year earlier amid "strong growth" in business volumes driven largely by the data-center sector.
$ASX:ORG
Asia
New Hope Says JPMorgan Chase Ceases to be a Substantial Shareholder
New Hope (ASX:NHC) received notice that JPMorgan Chase and its affiliates are no longer substantial holders of the company from April 22, according to a Monday filing with the Australian bourse.JPMorgan Chase and its affiliates became a substantial holder of the company on April 15, with a total voting power of 5.88%, an earlier filing showed.
$ASX:NHC
Asia
Zip Says JPMorgan Chase Increases Stake
Zip (ASX:ZIP) received notice that JPMorgan Chase and its affiliates increased their holdings in the company to 7.42% from 6.27%, according to a Monday Australian bourse filing.JPMorgan Chase and its affiliates now own 93.2 million shares in the company, the filing said.
$ASX:ZIP